Z-2574-2018 Class III Terminated
FDA device recall Z-2574-2018 was initiated by Diamedix Corporation on Jan 5, 2018 and is designated Class III. Reason for recall: Contains a gel-like contaminant that may affect product performance. The recall status is terminated (terminated Nov 5, 2019). Affected quantity: 147.
Recall details
- Product Type
- Devices
- Report Date
- Aug 8, 2018
- Initiation Date
- Jan 5, 2018
- Termination Date
- Nov 5, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 147
Product description
Diamedix Is-EBV-EA-D IgG Enzyme Immunoassay Test Kit for In Vitro Diagnostic Use Catalog No. 720-640
Reason for recall
Contains a gel-like contaminant that may affect product performance.
Distribution pattern
AZ, CA, FL, IL, IN, KY, MA, MI, MN, MO, NH, NJ, NY, OH, OK, PA, RI, TN, TX, and WI
Code information
Lot T0006 Exp. 05/31/2018
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2574-2018
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Diamedix Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.